A randomised, 2-period cross-over study to assess the feasibility of overnight computer-based glucose control based on the continuous subcutaneous glucose monitoring and to compare it with conventional pump therapy in adults with type 1 diabetes

Trial Profile

A randomised, 2-period cross-over study to assess the feasibility of overnight computer-based glucose control based on the continuous subcutaneous glucose monitoring and to compare it with conventional pump therapy in adults with type 1 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Apr 2011 Primary endpoint 'Glucose-level' has not been met.
    • 09 Dec 2009 Planned end date changed from 1 Jun 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
    • 04 Sep 2009 Status changed from not yet recruiting to completed as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top